- Home
- RAPT vs TPCS Comparison
RAPT vs TPCS Comparison
Compare RAPT & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- TPCS
- Stock Information
- Founded
- RAPT 2015
- TPCS 1956
- Country
- RAPT United States
- TPCS United States
- Employees
- RAPT N/A
- TPCS N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- TPCS Metal Fabrications
- Sector
- RAPT Health Care
- TPCS Industrials
- Exchange
- RAPT Nasdaq
- TPCS Nasdaq
- Market Cap
- RAPT 30.8M
- TPCS 32.1M
- IPO Year
- RAPT 2019
- TPCS N/A
- Fundamental
- Price
- RAPT $0.89
- TPCS $3.45
- Analyst Decision
- RAPT Hold
- TPCS
- Analyst Count
- RAPT 10
- TPCS 0
- Target Price
- RAPT $5.00
- TPCS N/A
- AVG Volume (30 Days)
- RAPT 386.3K
- TPCS 23.8K
- Earning Date
- RAPT 11-12-2024
- TPCS 11-12-2024
- Dividend Yield
- RAPT N/A
- TPCS N/A
- EPS Growth
- RAPT N/A
- TPCS N/A
- EPS
- RAPT N/A
- TPCS N/A
- Revenue
- RAPT N/A
- TPCS $32,205,714.00
- Revenue This Year
- RAPT N/A
- TPCS N/A
- Revenue Next Year
- RAPT N/A
- TPCS N/A
- P/E Ratio
- RAPT N/A
- TPCS N/A
- Revenue Growth
- RAPT N/A
- TPCS 1.51
- 52 Week Low
- RAPT $0.81
- TPCS $2.85
- 52 Week High
- RAPT $27.35
- TPCS $5.95
- Technical
- Relative Strength Index (RSI)
- RAPT 36.23
- TPCS 46.75
- Support Level
- RAPT $0.84
- TPCS $3.25
- Resistance Level
- RAPT $1.18
- TPCS $4.01
- Average True Range (ATR)
- RAPT 0.10
- TPCS 0.24
- MACD
- RAPT 0.01
- TPCS -0.02
- Stochastic Oscillator
- RAPT 17.00
- TPCS 26.32
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.